Endo International PLC | Ownership
Companies that own Endo International PLC
BlackRock Fund Advisors
30,509,795
13.63%
10,458,021
0.03%
06/30/2018
Glenview Capital Management LLC
22,288,422
9.94%
800,000
2.27%
06/30/2018
The Vanguard Group, Inc.
20,172,067
9.01%
3,056,281
0.01%
06/30/2018
Renaissance Technologies LLC
10,040,549
4.48%
2,005,649
0.18%
06/30/2018
Miller Value Partners LLC
9,694,740
4.33%
-51,590
5.57%
06/30/2018
Paulson & Co., Inc.
9,174,500
4.09%
0
2.96%
06/30/2018
Dimensional Fund Advisors LP
8,384,077
3.74%
-2,336,398
0.04%
06/30/2018
SSgA Funds Management, Inc.
6,780,544
3.03%
-529,819
0.01%
06/30/2018
Citigroup Global Markets, Inc. (Investment Management)
5,462,039
2.44%
5,397,698
0.26%
06/30/2018
Morgan Stanley & Co. LLC
5,020,889
2.24%
97,752
0.1%
06/30/2018
| Address |
Minerva House
Dublin Dublin 4
Ireland
|
|
Employees
|
- |
| Website |
http://www.endo.com |
| Updated |
07/08/2019 |
| Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The company operates through the following segments: U. |
